PMID: 19927485Nov 26, 2009Paper

Topical apraclonidine to diagnose Bernard-Horner syndrome

Bulletin de la Société belge d'ophtalmologie
M KocaboraM Taskapili

Abstract

This study aimed at developing through three clinical cases, the usefulness of topical apraclonidine 0.5% to confirm a diagnosis of Bernard-Horner syndrome. Pupil diameter measurements were performed in indoor, bright and dim light successively. Apraclonidine 0.5% was then applied topically to both eyes, and pupils were observed at 30 and 60 minutes. Apraclonidine demonstrated denervation hypersensitivity in all three cases. Anisocoria was reversed in two cases and corrected in the third case. Although the cocaine test should still be considered as the gold standard for BHS diagnosis, apraclonidine seems to be a useful drug to confirm clinically diagnosed Bernard-Horner syndrome

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Archivos de la Sociedad Española de Oftalmología
M A Pérez-IñigoF M Honrubia
Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
Kenn A Freedman, Sandra M Brown
Klinische Monatsblätter für Augenheilkunde
Aki Kawasaki, F-X Borruat
Ophthalmic Plastic and Reconstructive Surgery
Daniel C GaribaldiShannath L Merbs
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics
Po-Liang ChenChih-Hsien Hsiao
© 2022 Meta ULC. All rights reserved